A Promising, Novel Radiosensitizer Nanodrug Complex for Oral Cavity Cancer: Cetuximab and Cisplatin-Conjugated Gold Nanoparticles

• Şeniz İnanç Sürer,
• Tarık Buğra Elçitepe,
• Doğukan Akçay,
• Ezgi Daşkın,
• Gizem Çalıbaşı Kocal,
• Zümre Arıcan Alıcıkuş,
• Görkem Eskiizmir,
• Kerim Yapıcı,
• Yasemin Başbınar

Affiliations

Şeniz İnanç Sürer

Department of Medical Biochemistry, Dokuz Eylül University School of Medicine, İzmir, Turkey

Tarık Buğra Elçitepe

Department of Energy Science and Technology, Cumhuriyet University, Sivas, Turkey

Doğukan Akçay

Department of Radiation Oncology, Dokuz Eylül University School of Medicine, İzmir, Turkey

Ezgi Daşkın

Department of Translational Oncology, Institute of Health Sciences, Dokuz Eylül University, İzmir, Turkey

Gizem Çalıbaşı Kocal

Department of Translational Oncology, Institute of Oncology, Dokuz Eylül University, İzmir, Turkey

Zümre Arıcan Alıcıkuş

Department of Radiation Oncology, Dokuz Eylül University School of Medicine, İzmir, Turkey

Görkem Eskiizmir

Department of Otolaryngology-Head and Neck Surgery, Manisa Celal Bayar University School of Medicine, Manisa, Turkey

Kerim Yapıcı

Department of Chemical Engineering, Süleyman Demirel University, Isparta, Turkey

Yasemin Başbınar

Department of Translational Oncology, Institute of Oncology, Dokuz Eylül University, İzmir, Turkey